In honor of Ovarian Cancer Awareness Month and Hereditary Breast and Ovarian Cancer Week, SHARE, Facing Our Risk (FORCE) and NYU co-sponsored a talk with Dr. Douglas Levine, Director of Gynecologic Oncology and Head of Gynecologic Oncology Research Laboratory at NYU Langone Medical Center. Dr. Levine discussed the recent developments in ovarian cancer screening and prevention, particularly the research showing that many cases of ovarian cancer start in the Fallopian tubes.
These exciting new technologies and strategies for ovarian cancer screening--though a few years from widespread use--could have major implications for those at a high risk for developing ovarian cancer due to BRCA1 and BRCA2 genes. Though these screening techniques are in the early stages of development, they could help detect ovarian cancer in high risk women at earlier stages.
SHARE's Ovarian team (pictured below with Dr. Levine), including the new Ovarian Cancer Program Director Stephanie Blaufarb, were on hand at the event to learn how these findings would impact their work.
(l to r: Deb Polinsky, SHARE's Ovarian Cancer Support Group Facilitator; Andrea Herzberg, SHARE's Ovarian Helpline Coordinator; Dr. Doulgas Levine of NYU; Stephanie Blaufarb, SHARE's Ovarian Cancer Program Director).
"It's amazing to see the impact new research is making on the way we understand and approach this disease," Ms. Blaufarb said.
Visit SHARE's Ovarian Cancer Educational Programs Page to find out about similar events like this in the future. A recording of Dr. Levine's talk will also be posted shortly in our Ovarian Cancer Video Library- stay tuned!